Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on March 24, 2025
Satellogic Reports 2024 Financial Results and Business Update
GlobeNewswire
·
March 24, 2025
Revenue up 28% to $12.9 million in 2024 Redomicile to U.S. Nears Completion; Set to Accelerate Market Opportunities Completed $10 Million Private Placement Entered into $50 Million At-The-Market (ATM) Program NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- …
Beyond Oil Announces Start of Commercialization of India Distribution Agreement; First Payment Received
GlobeNewswire
·
March 24, 2025
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, March 24, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) (“Beyond Oil” or the “Company”), a food-tech innovation company dedicated to reducing health risks associated with fried …
Rainbow Realty Group Completes $12 Million Senior Real Estate Mortgage Loan to Verano Holdings Corp
GlobeNewswire
·
March 24, 2025
NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Rainbow Realty Group IV, LLC ("Rainbow"), in collaboration with Rainbow Realty Group II, LLC, and MJ Real Estate Investment Trust ("MJ REIT"), has successfully closed a $12 million cross-collateralized senior …
Enerpac Tool Group Reports Second Quarter Fiscal 2025 Results
GlobeNewswire
·
March 24, 2025
Second Quarter of Fiscal 2025 Continuing Operations Highlights* Net sales were $146 million, a 5.1% increase compared to the prior year, with a 5.0% increase in organic sales.1 Operating profit margin was 21.2% and adjusted operating profit margin was 21. …
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 24, 2025
BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025 BDC-3042 Phase 1 clinical trial fully enrolled the highest dose cohort with no dose-limiting toxicities (DLTs), results will be reported in second quarter 2025 Cash …
RedCloud Holdings Announces Closing of $20 Million Initial Public Offering
GlobeNewswire
·
March 24, 2025
LONDON, March 24, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (“RedCloud” or the “Company”), today announced the closing of its initial public offering of 4,444,445 of its ordinary shares at a public offering price of $4.50 per share (the “Offering”). …
Prairie Operating Co. Announces Registered Direct Offering of Series F Convertible Preferred Stock and Warrants to Purchase Common Stock
GlobeNewswire
·
March 24, 2025
HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Prairie Operating Co. (“Prairie,” the “Company,” “we” or “our”) (Nasdaq: PROP), an independent oil and gas company focused on the acquisition and development of crude oil, natural gas and natural gas liquids, …
Parsons’ Board Approves $250 Million Share Repurchase Authorization
GlobeNewswire
·
March 24, 2025
CHANTILLY, Va., March 24, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that its board of directors has increased the company’s stock repurchase authorization to $250 million. “Parsons’ strong operating results and cash flow …
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire
·
March 24, 2025
Initial data for AlloNK® from autoimmune program expected H1 2025 Updated clinical data from Phase 1/2 trial exploring AlloNK + rituximab in NHL showing continued durability of response to be presented at a medical conference in 2025 Strengthened key …
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
GlobeNewswire
·
March 24, 2025
First-in-human studies anticipated to begin in 2026 Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of quality Currently in the advanced stages of formulation development for subcutaneous injection, with plans for an …
AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 24, 2025
– Initiated analytical studies in Q4 2024 to prepare for a potential Biosimilar Biological Product Development (“BPD”) Type 2a meeting with the FDA in the second half of 2025 – – Pursuing a 351(k) regulatory pathway for ABP-450, which offers potential …
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
GlobeNewswire
·
March 24, 2025
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million GraftAssure RUO assay launched July 2024 Signed strategic partner and investor, Bio-Rad Laboratories Fully funded clinical kitted product development with $50+ million in …
Dragonfly Energy Reports Fourth Quarter and Full Year 2024 Results
GlobeNewswire
·
March 24, 2025
Fourth Quarter Revenue Growth of 17% Led by Significant OEM Growth Debt Restructuring and Concurrent Capital Raise Enhance Financial Position and Liquidity Initiates Corporate Optimization Program Guides to First Quarter 2025 Net Sales of Approximately $13 …
Nasdaq to Hold First Quarter 2025 Investor Conference Call
GlobeNewswire
·
March 24, 2025
NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its first quarter 2025 financial results announcement. Who: Nasdaq’s CEO, CFO, and additional members of its senior management team What: Review Nasdaq …
Prairie Operating Co. Announces Public Offering of Common Stock
GlobeNewswire
·
March 24, 2025
HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Prairie Operating Co. (“Prairie,” the “Company,” “we,” or “our”) (Nasdaq: PROP), an independent oil and gas company focused on the acquisition and development of crude oil, natural gas and natural gas liquids, …
MiLi MiTag Duo - The World’s First Apple and Google Licensed Bluetooth Tracker in One Device
GlobeNewswire
·
March 24, 2025
Shenzhen, China, March 24, 2025 (GLOBE NEWSWIRE) -- MiLi, a leader in smart accessories with over 20 years of innovation, is redefining Bluetooth tracking with MiTag Duo—the first tracker officially licensed by both Apple and Google in one single device. …
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
GlobeNewswire
·
March 24, 2025
Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; Supports Front-Line Treatment Potential Clinical Pipeline Continues to Advance with Phase 3 CoMpass Trial …
Acutus Medical Reports Full Year 2024 Financial Results
GlobeNewswire
·
March 24, 2025
CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024. Recent Highlights: 2024 Revenue from Continuing Operations of $20.2 million grew 181% year- …
SKYX Reports 48% Revenue Growth in 2024 — From $58.8 Million in 2023 to $86.3 Million in 2024
GlobeNewswire
·
March 24, 2025
Sales of SKYX’s Advanced and Smart Home Related Products Surge Over 1,000%; SKYX Expects its products to be in 20,000 Units/Homes by Q1 2025 and an Additional Tens of Thousands of Units/Homes in 2025 Company Expects Significant Projects and Orders and to …
Marex Group plc Provides Details for Upcoming Investor Day on April 2, 2025
GlobeNewswire
·
March 24, 2025
NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’), the diversified global financial services platform, provides details for its upcoming Investor Day being held at the Nasdaq MarketSite in New York on April 2, 2025. The event will …